The global demand for Immunogenetics Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Immunogenetics studies the mechanisms underlying autoimmune diseases, organ transplant tolerance, and immunity to infectious diseases. Immunogenetics comprises two terms, ' immunology' and 'genetics'. Immunology is the biological foundation of the body's defence against foreign agents such as natural toxins, bacteria, viruses, fungi, etc. Genetics refers to studying an organism's genes and the transfer of genes from parent to child generation in the context of possible variations. The primary focus of immunogenetics is the treatment of autoimmune diseases.
Immunogenetics market growth is being fueled by the growing physician and patient awareness of the benefits of immunogenetics. Furthermore, increasing incidence of targeted diseases such as cancer, arthritis and others, accurate and reliable results and growth and expansion of the healthcare industry in the developing economies are also expected to drive the growth of the immunogenetics market. In addition, the increase in R&D in biopharmaceutical and biotechnology companies is propelling the global immunogenetics market growth. However, the high investment involved and stringent rules and regulations by governing authorities restrain the growth of the immunogenetics market, whereas a lack of professionals will challenge market growth.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of immunogenetics. The growth and trends of immunogenetics industry provide a holistic approach to this study.
This section of the immunogenetics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By End User
- Multiple Sclerosis
- Rheumatoid Arthritis
- Crohn’S Disease
- Diabetes Mellitus Type 1
- Diagnostic Centers
- Academic And Research Institute
This section covers the regional outlook, which accentuates current and future demand for the Immunogenetics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Immunogenetics Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the immunogenetics market include AbbVie Inc., Janssen Global Services, LLC, F. Hoffmann-La Roche Ltd, Amgen Inc., Pfizer Inc., Novartis AG, Astellas Pharma Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., UCB S.A., Allergan, Eli Lilly and Company, CELGENE CORPORATION, Bionor Holding AS, CELLECTAR BIOSCIENCES, INC., eFFECTOR Therapeutics, Inc., Bristol-Myers Squibb Company, Abbott, Medtronic, BD, Cook and Boehringer Ingelheim International GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.